Novo Nordisk A/S Common Stock (NVO)

Retained Earnings

kr 224.16B

Quarterly · Period ending: · DKK

NVO logo

NVO Retained Earnings

Latest reportedkr 224.16B DKK
NVO Quarterly Retained Earnings · DKK (kr 2.87B → kr 224.16B)
High-resolution chart · PNG

NVO retained earnings history

Quarterly · DKK. Dates are reporting period ends; fiscal years can differ from calendar years.

Novo Nordisk A/S Common Stock Retained Earnings — Quarterly (DKK)
Period endingRetained Earnings (DKK)
224,164,000,000
206,420,000,000
195,298,000,000
168,529,000,000
164,453,000,000
137,319,000,000
144,448,000,000
121,670,000,000
16,117,674,111
99,050,000,000
104,839,000,000
13,024,619,491
12,911,346,036
11,240,346,821
80,587,000,000
9,706,715,503
10,285,730,352
9,963,876,236
72,004,000,000
10,584,934,773
10,713,414,293
9,528,678,323
10,483,110,051
9,428,537,670
9,043,769,166
8,065,815,786
8,685,143,458
53,721,000,000
53,558,000,000
48,584,000,000
53,406,000,000
49,007,000,000
50,671,000,000
43,652,000,000
48,977,000,000
45,262,000,000
47,014,000,000
40,739,000,000
46,111,000,000
41,056,000,000
42,510,000,000
36,070,000,000
46,816,000,000
42,797,000,000
39,353,000,000
34,790,000,000
41,277,000,000
38,743,000,000
36,105,000,000
32,365,000,000
41,137,000,000
37,818,000,000
34,130,000,000
32,508,000,000
39,001,000,000
34,607,000,000
30,839,000,000
31,287,000,000
37,111,000,000
34,855,000,000
35,440,000,000
33,258,000,000
36,097,000,000
33,690,000,000
33,053,000,000
32,330,000,000
35,146,000,000
33,565,000,000
33,369,000,000
31,691,000,000
33,512,738,000
31,915,074,450
31,165,636,800
29,476,012,350
30,699,342,000
31,730,332,500
32,130,464,850
28,440,674,080
28,812,409,400
27,010,189,920
27,570,984,800
25,960,484,550
26,924,298,580
25,916,551,800
25,054,765,950
24,793,895,340
22,829,289,600
22,136,258,610
21,534,393,660
20,500,472,070
21,149,727,900
19,024,830,720
16,415,629,650
12,352,648,000
14,689,910,870
14,457,038,498
14,593,053,726
12,609,375,408
11,013,062,400
9,733,088,540
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.